{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:56:19Z","timestamp":1778586979664,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["XDJK2011C049"],"award-info":[{"award-number":["XDJK2011C049"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Program of Chongqing Science and Technology Research Project","award":["cstc2013jcsf10002"],"award-info":[{"award-number":["cstc2013jcsf10002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.lfs.2015.01.033","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T18:12:30Z","timestamp":1425319950000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats"],"prefix":"10.1016","volume":"128","author":[{"given":"Xuemei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2015.01.033_bb0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amepre.2008.11.020","article-title":"Obesity among those with mental disorders: a National Institute of Mental Health Meeting Report","volume":"36","author":"Allison","year":"2009","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.lfs.2015.01.033_bb0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6","article-title":"Pharmacokinetics and tissue distribution of olanzapine in rats","volume":"20","author":"Aravagiri","year":"1999","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.lfs.2015.01.033_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0091270006296151","article-title":"Selegiline transdermal system: an examination of the potential for CYP450-dependent pharmacokinetic interactions with 3 psychotropic medications","volume":"47","author":"Azzaro","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","article-title":"Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions","volume":"28","author":"Birkenaes","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"Correl","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"issue":"Supplement 2","key":"10.1016\/j.lfs.2015.01.033_bb0030","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.lfs.2015.01.033_bb0035","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1039\/c1an15155j","article-title":"Development of a simple and stability-indicating RP-HPLC method for determining olanzapine and related impurities generated in the preparative process","volume":"136","author":"Cui","year":"2011","journal-title":"Analyst"},{"key":"10.1016\/j.lfs.2015.01.033_bb0040","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ecl.2013.05.006","article-title":"Effects of antipsychotic medications on appetite, weight, and insulin resistance","volume":"42","author":"Deng","year":"2013","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.lfs.2015.01.033_bb0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0269881112449396","article-title":"Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model","volume":"26","author":"Deng","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0050","series-title":"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"FDA","year":"2005"},{"key":"10.1016\/j.lfs.2015.01.033_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/0269881107082287","article-title":"Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats","volume":"22","author":"Fell","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","article-title":"Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?","volume":"5","author":"Fern\u00f8","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.lfs.2015.01.033_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2741\/3675","article-title":"Lipogenic effects of psychotropic drugs: focus on the SREBP system","volume":"16","author":"Fern\u00f8","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.lfs.2015.01.033_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-008-1370-x","article-title":"Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver","volume":"203","author":"Fern\u00f8","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2015.01.033_bb0075","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1365-2826.2003.01096.x","article-title":"White adipose tissue: getting nervous","volume":"15","author":"Fliers","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0080","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1128\/MCB.19.5.3760","article-title":"ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose","volume":"19","author":"Foretz","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0085","doi-asserted-by":"crossref","first-page":"792456","DOI":"10.1155\/2013\/792456","article-title":"Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs","volume":"2013","author":"Gervasini","year":"2013","journal-title":"ISRN Pharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0090","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/ptr.3204","article-title":"Berberine inhibits SREBP-1-related clozapine and risperidone induced adipogenesis in 3T3-L1 cells","volume":"24","author":"Hu","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0095","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.lfs.2015.01.033_bb0100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1517\/14740330802423234","article-title":"Olanzapine: review of safety 2008","volume":"7","author":"Kantrowitz","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.lfs.2015.01.033_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(99)00053-5","article-title":"Differential olanzapine plasma concentrations by sex in a fixed-dose study","volume":"40","author":"Kelly","year":"1999","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0110","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1101\/gad.10.9.1096","article-title":"ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism","volume":"10","author":"Kim","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2015.01.033_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/14728222.8.2.141","article-title":"Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?","volume":"8","author":"Kotzka","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2015.01.033_bb0120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI0215736","article-title":"Selective parasympathetic innervation of subcutaneous and intra-abdominal fat\u2014functional implications","volume":"110","author":"Kreier","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2015.01.033_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00210-010-0597-3","article-title":"Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver","volume":"383","author":"Lauressergues","year":"2011","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0130","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-010-0499-4","article-title":"Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes","volume":"381","author":"Lauressergues","year":"2010","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pnpbp.2013.08.005","article-title":"Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density","volume":"47","author":"Lian","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2015.01.033_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.lfs.2015.01.033_bb0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.pbb.2012.12.002","article-title":"Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition","volume":"103","author":"Mann","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.lfs.2015.01.033_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2015.01.033_bb0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/01902140500248613","article-title":"Organ-cultured airway explants: a new model of airway hyperresponsiveness","volume":"31","author":"Morin","year":"2005","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.lfs.2015.01.033_bb0165","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00502.2010","article-title":"Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism","volume":"300","author":"Oh","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2015.01.033_bb0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1079\/PNS19830031","article-title":"Fatty acid synthesis in liver and adipose tissue","volume":"42","author":"Pearce","year":"1983","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2015.01.033_bb0175","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11010-006-9160-4","article-title":"SREBP activation by antipsychotic- and antidepressant-drugs in cultured human liver cells: relevance for metabolic side-effects?","volume":"289","author":"Raeder","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2015.01.033_bb0180","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2015.01.033_bb0185","first-page":"350","article-title":"The incidence of dyslipidemia (hypertriglyceridemia and hypercholesterolemia) in patients treated with the new generation of antipsychotic drugs compared to conventional therapy","volume":"11","author":"Sadibasic","year":"2014","journal-title":"Med. Glas. (Zenica)"},{"key":"10.1016\/j.lfs.2015.01.033_bb0190","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"Sarvari","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2015.01.033_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00041433-200104000-00006","article-title":"Structure, function and regulation of the ABC1 gene product","volume":"12","author":"Schmitz","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0200","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.pnpbp.2011.07.017","article-title":"Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism","volume":"35","author":"Sertie","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2015.01.033_bb0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/138920010791636202","article-title":"Atypical antipsychotic metabolism and excretion","volume":"11","author":"Sheehan","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.lfs.2015.01.033_bb0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk?","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.lfs.2015.01.033_bb0225","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-0495(00)80033-5","article-title":"Comparative study of the lipogenic potential of human and rat adipose tissue","volume":"49","author":"Swierczynski","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2015.01.033_bb0230","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2007.11.078","article-title":"Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution","volume":"585","author":"van der Zwaal","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0240","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.euroneuro.2011.09.003","article-title":"Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels","volume":"22","author":"Weston-Green","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.lfs.2015.01.033_bb0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2007.05.007","article-title":"Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells","volume":"56","author":"Yang","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2015.01.033_bb0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2008.12.029","article-title":"Activation of muscarinic M-3 receptor may decrease glucose uptake and lipolysis in adipose tissue of rats","volume":"451","author":"Yang","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.lfs.2015.01.033_bb4000","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin Pharmacokinet"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515001022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515001022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:29:29Z","timestamp":1589502569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515001022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":51,"alternative-id":["S0024320515001022"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.01.033","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}